Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization

Journal of Clinical Oncology

Volumn 16, Issue 4, 1998, Pages 1554-1560

  Watts, Michael John ^a   Sullivan, Angela Michelle ^a   Leverett, David ^a   Peniket, Andrew J ^a   Perry, Amanda R ^a   Williams, Catherine D ^a   Devereux, Steven ^a   Goldstone, Anthony H ^a   Linch, David C ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; COLONY FORMING UNIT GM; FEMALE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM TUMOR; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOMA; NEUTROPHIL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SOLID TUMOR; STEM CELL TRANSPLANTATION; THROMBOCYTE;

EID: 0031950148     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.4.1554     Document Type: Article

References (25)

1. Linch DC, Winfield D, Goldstone AH, et al: Dose intensification with autologous bone marrow transplantation is effective in relapsed and resistant Hodgkin's Disease: Results of a BNLI randomized trial. Lancet 341:138-142, 1993
2. Philip T, Guglielmi C, Hagenbeek A, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540-1545, 1995
3. Haioun C, Lepage E, Gisselbrecht C, et al: Autologous bone marrow transplantation (ABMT) versus sequential chemotherapy for agressive non-Hodgkin's lymphoma (NHL) in first remission (CR): A study of 542 patients (LNH87-2 protocol). Blood 86:457A, 1995 (abstr 1815)
4. Bezwoda WR, Seymour L, Dansey RD: High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial. J Clin Oncol 13:2483-2489, 1995
5. Attal M, Harousseau JL, Stoppa AM, et al: A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91-97, 1996
6. Spitzer G, Verma DS, Fisher R, et al: The myeloid progenitor cell - it's value in predicting hematopoietic recovery after autologous bone marrow transplantation. Blood 55:317-323, 1980
7. Gorin NC: Collection, manipulation and freezing of haematopoietic stem cells. Clin Haematol 15:19-48, 1986
8. Arnold R, Schmeiser T, Heit W, et al: Hematopoietic reconstitution after bone marrow transplantation. Exp Hematol 14:271-277, 1986
9. Jones HM, Jones SA, Watts MJ, et al: Development of a simplified apheresis approach for PBSC transplantation in previously treated patients with lymphoma. J Clin Oncol 12:1693-1702, 1994
10. Beyer J, Schwella N, Zingsem J, et al: Hematopoietic rescue after high-dose chemotherapy using autologous peripheral blood progenitor cells or bone marrow: A randomized comparison. J Clin Oncol 13:1328-1335, 1995
11. Schmitz N, Linch DC, Dreger P, et al: Randomised trial of filgrastim mobilised peripheral blood progenitor cell transplant versus autologous bone marrow transplantation in lymphoma patients. Lancet 347:353-357, 1996
12. Smith TJ, Hillner BE, Schmitz N, et al: Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma. J Clin Oncol 15:5-10, 1997
13. Bensinger WI, Longin K, Appelbaum F, et al: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825-831, 1994
14. Demirer T, Besinger WI: Optimisation of peripheral blood stem cell collection. Curr Opin Haematol 2:219-226, 1995
15. Watts MJ, Sullivan AM, Jamieson E, et al: Progenitor cell mobilization after low-dose cyclophosphamide and G-CSF: An analysis of progenitor cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol 15:535-546, 1997
16. Serke S, Watts MJ, Knudsen LM, et al: In vitro clonogenicity of mobilized peripheral blood CD34-expressing cells: Inverse correlation to both relative and absolute numbers of CD34-expressing cells. Brit J Haematol 95:234-240, 1996
17. Bensinger WI, Appelbaum F, Rowlcy S, et al: Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 13:2547-2555, 1995
18. Haas R, Mohle R, Fruhauf S, et al: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787-3794, 1994
19. Passos-Coelho JL, Braine HG, Davis JM, et al: Predictive factors for peripheral blood progenitor cell collections using a single large volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 13:705-714, 1995
20. Dreger P, Kloss M, Petersen B, et al: Autologous progenitor cell transplantation: Prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 86:3970-3978, 1995
21. Makino S, Harada M, Akashi K, et al: A simplified method for cryopreservation of peripheral blood stem cells at -80°C without rate-controlled freezing. Bone Marrow Transplant 4:239-244, 1991
22. Watts MJ, Jones HM, Sullivan AM, et al: Accessory cells do not contribute to G-CSF or IL-6 production nor to rapid haematological recovery following peripheral blood stem cell transplantation. Brit J Haematol 91:767-772, 1995
23. Scott MA, Ager S, Jestice HK, et al: Failure to mobilize and harvest PBPC does not necessarily preclude the use of high-dose therapy and autologous stem-cell rescue. Bone Marrow Transplant 15:487-488, 1995 (letter)
24. Weaver CH, Hazelton B, Birch R, et al: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:3961-3969, 1995
25. Khwaja A, Mills W, Leveridge K, et al: Efficacy of delayed G-CSF after autologous bone marrow transplantation. Bone Marrow Transplant 11:479-482, 1993